ICARES Medicus, Inc. (TPEX:6612)
Taiwan
· Delayed Price · Currency is TWD 111.00
-1.00 (-0.89%)
Apr 30, 2025, 1:30 PM CST
ICARES Medicus Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 4,725 | 5,278 | 4,934 | 2,774 | 2,337 | 2,101 | Upgrade
|
| Market Cap Growth | 6.98% | 6.98% | 77.87% | 18.70% | 11.21% | -28.34% | Upgrade
|
| Enterprise Value | 5,017 | 5,440 | 4,633 | 2,403 | 2,093 | 1,879 | Upgrade
|
| Last Close Price | 111.00 | 124.00 | 114.41 | 72.22 | 60.86 | 55.02 | Upgrade
|
| PE Ratio | 46.25 | 51.19 | 50.49 | 21.52 | 39.88 | 40.48 | Upgrade
|
| PS Ratio | 5.50 | 6.14 | 8.15 | 5.42 | 5.93 | 5.80 | Upgrade
|
| PB Ratio | 2.68 | 2.99 | 2.96 | 2.96 | 2.85 | 2.99 | Upgrade
|
| P/TBV Ratio | 6.27 | 7.00 | 3.38 | 3.64 | 3.98 | 4.20 | Upgrade
|
| P/FCF Ratio | - | - | - | 28.46 | 70.43 | 33.76 | Upgrade
|
| P/OCF Ratio | - | - | - | 21.52 | 60.60 | 29.45 | Upgrade
|
| EV/Sales Ratio | 5.84 | 6.33 | 7.65 | 4.69 | 5.31 | 5.18 | Upgrade
|
| EV/EBITDA Ratio | 23.54 | 30.20 | 35.83 | 16.84 | 19.58 | 18.87 | Upgrade
|
| EV/EBIT Ratio | 39.94 | 44.14 | 42.68 | 19.27 | 23.82 | 23.93 | Upgrade
|
| EV/FCF Ratio | -31.40 | - | - | 24.65 | 63.07 | 30.18 | Upgrade
|
| Debt / Equity Ratio | 0.53 | 0.53 | 0.09 | 0.01 | 0.02 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 4.46 | 4.46 | 0.95 | 0.04 | 0.15 | 0.22 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.06 | 0.53 | 0.37 | Upgrade
|
| Asset Turnover | 0.35 | 0.35 | 0.41 | 0.51 | 0.43 | 0.44 | Upgrade
|
| Inventory Turnover | 1.11 | 1.11 | 1.18 | 1.37 | 1.32 | 1.46 | Upgrade
|
| Quick Ratio | 1.75 | 1.75 | 9.07 | 6.01 | 4.00 | 5.48 | Upgrade
|
| Current Ratio | 2.46 | 2.46 | 10.45 | 7.11 | 4.81 | 6.67 | Upgrade
|
| Return on Equity (ROE) | 3.18% | 3.18% | 4.94% | 12.55% | 4.91% | 5.45% | Upgrade
|
| Return on Assets (ROA) | 3.13% | 3.13% | 4.60% | 7.76% | 6.05% | 5.98% | Upgrade
|
| Return on Capital (ROIC) | 3.41% | 3.41% | 4.92% | 8.75% | 7.02% | 6.97% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.10% | 5.10% | 6.10% | 13.10% | 10.30% | 10.00% | Upgrade
|
| Earnings Yield | 2.18% | 1.95% | 1.98% | 4.65% | 2.51% | 2.47% | Upgrade
|
| FCF Yield | -3.38% | -3.03% | -1.96% | 3.51% | 1.42% | 2.96% | Upgrade
|
| Dividend Yield | 0.27% | 0.24% | 0.16% | 1.26% | 0.75% | 0.17% | Upgrade
|
| Payout Ratio | 7.59% | 7.60% | 34.96% | 13.18% | 5.80% | 32.49% | Upgrade
|
| Buyback Yield / Dilution | -11.53% | -11.53% | -2.91% | -0.74% | -0.38% | -0.39% | Upgrade
|
| Total Shareholder Return | -11.26% | -11.29% | -2.75% | 0.52% | 0.36% | -0.22% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.